RTI wins FDA nod for device used in soft tissue repair

03/14/2013 | RTT News

The FDA has given RTI Biologics 510(k) clearance to market its porcine dermis implantable device, which is intended for use in hernia repair and other soft tissue fixation procedures. The device, slated for U.S. distribution later this year, serves as a scaffold that can be used for neovascularization or that can be reincorporated with the patient's own tissue.

View Full Article in:

RTT News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA